BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okuyama K, Yanamoto S. TMEM16A as a potential treatment target for head and neck cancer. J Exp Clin Cancer Res 2022;41:196. [PMID: 35668455 DOI: 10.1186/s13046-022-02405-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang H, Zhang Z, Guan Z, Zheng S, Lou J, Liu W, Cai Q, Si Y. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1096220] [Reference Citation Analysis]
2 Bai X, Cheng Y, Wan H, Li S, Kang X, Guo S. Natural Compound Allicin Containing Thiosulfinate Moieties as Transmembrane Protein 16A (TMEM16A) Ion Channel Inhibitor for Food Adjuvant Therapy of Lung Cancer. J Agric Food Chem 2023;71:535-45. [PMID: 36574498 DOI: 10.1021/acs.jafc.2c06723] [Reference Citation Analysis]
3 Hashemi M, Mirzaei S, Barati M, Hejazi ES, Kakavand A, Entezari M, Salimimoghadam S, Kalbasi A, Rashidi M, Taheriazam A, Sethi G. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects. Life Sci 2022;309:120984. [PMID: 36150461 DOI: 10.1016/j.lfs.2022.120984] [Reference Citation Analysis]